Who received a Tuberculin Skin Test and Isoniazid Preventive Therapy in the THRio study?

Date:

April 23, 2015 (All Day)

Mariana Soares Puppin talks about who receieved a Tuberculin Skin Test and Isoniazid Preventive Therapy during the THRio study.

Video/Audio/Slides

Audio-only/Slides

Projects

APT: Assessing PA-824 for Tuberculosis

A Phase 2 clinical trial of PA-824, an investigational nitroimidazole, as part of multidrug therapy for pulmonary TB; in...

Read More

MDR TB treatment as prevention: modeling the...

We are using transmission modeling to evaluate the potential impact of expanding DST and access to MDR TB treatment in Vietnam,...

Read More

Understanding the role of repeat testing and...

We have developed a Markov model of serial IGRA testing to help improve testing algorithms with TST vs. IGRA in low-risk...

Read More

Modeling the impact of spatially targeted TB...

We have developed transmission models to understand the impact of TB vaccination strategies that target hotspots of...

Read More